TD Cowen Maintains Hold on Qiagen, Lowers Price Target to $40

Benzinga Newsdesk www.benzinga.com Negative 78.0%

Neg 78% Neu 0% Pos 0%

TD Cowen analyst Dan Brennan maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $46 to $40.

Comments

No comments yet. Be the first!